Monika Rajput

Dr. Monika Rajput

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Materialia
Verified
Journal Article
Closed access
MRMonika Rajput
Monika Rajput
MMMousumi Mandal
Mousumi Mandal
AAAnji Anura
Anji Anura
AMAnurup Mukhopadhyay
Anurup Mukhopadhyay
BSBhuvaneshwaran Subramanian
Bhuvaneshwaran Subramanian
JCJyotirmoy Chatterjee
Jyotirmoy Chatterjee

1 September 2014 in RSC Advances
Verified
Journal Article
Closed access
PDF file
MRMonika Rajput
Monika Rajput
NBNandini Bhandaru
Nandini Bhandaru
ABAnanya Barui
Ananya Barui
ACAmrita Chaudhary
Amrita Chaudhary
RPRanjan Rashmi Paul
Ranjan Rashmi Paul
JCJyotirmoy Chatterjee
Jyotirmoy Chatterjee
The desirable properties of a matrix for tissue engineering applications appears to shift from a minimal model of supporting cell growth to a more inclusive role as a matrix to trigger the regeneration process. This requirement has propelled efforts towards bio-functionalization of matrices both by chemical and textural modification of most advanced materials, including silk. Amongst different biomaterials, silk fibroin (SF) has been extensively used for various tissue engineering applications, because of its low immunogenicity and good mechanical strength, although low biological activity and a poor biodegradability rate has remained its major limitation for use in regenerative medicine. In the present study, the physical as well as biological properties of SF have been improved by incorporation of honey, a natural healing agent. Honey-blended SF films (HSF) demonstrated increased mechanical strength together with enhanced wettability, swelling ability and degradability without hampering the original mechanical and biological properties of both honey and SF. In addition, parallel-aligned nanostructures were produced over native SF and HSF using soft lithography to form two-dimensional nano-patterned membranes. HSF films demonstrated enhanced surface roughness in flat membranes and even more so in nano-patterned membranes when compared with native SF membranes which are essential for cellular adhesion and proliferation. Furthermore, biocompatibility and cellular behavior such as adhesion, proliferation, spreading and interaction of 3T3 fibroblast cells were improved using HSF when compared with using native SF membranes. Thus, HSF membranes with enhanced bio-physical properties are a potential material for use in regenerative medicine and tissue engineering applications.

2 August 2016 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
MRMonika Rajput
Monika Rajput
NBNandini Bhandaru
Nandini Bhandaru
AAAnji Anura
Anji Anura
MPMousumi Pal
Mousumi Pal
BPBarnali Pal
Barnali Pal
RMRabibrata Mukherjee
Rabibrata Mukherjee

29 June 2025 in Advanced Functional Materials
Verified
Journal Article
Open access
MRMonika Rajput
Monika Rajput
YTYen‐Ting Tung
Yen‐Ting Tung
YCYu‐Chi Chen
Yu‐Chi Chen
MSMin Jae Song
Min Jae Song
MFMarc Ferrer
Marc Ferrer
ELEmily Lee
Emily Lee
Flaviviruses can lead to severe neurotropic‐encephalitic pathology, for which the viral nonstructural protein 1 (NS1) plays a major role. 2D in vitro cellular systems and animal models are currently used to investigate the effects of flavivirus NS1 in the brain‐blood barrier do not fully capture pathogenesis and drug responses seen in humans. Here is reported the development of a perfusable human brain microvascular network‐on‐a‐chip (BMVasChip) model which incorporates brain endothelial cells and pericytes and recapitulates the cellular organization and expression of brain blood barrier‐specific markers, including intracellular junction proteins. This BMVasChip model is used to investigate vasculopathy caused by exposure to a panel of flavivirus NS1 proteins, including Japanese encephalitis (JEV), West Nile (WNV), and dengue virus (DENV) NS1 proteins. The BMVasChip platform is able to demonstrate flavivirus NS1‐induced pathophysiological phenotypes in the BMVasChip, including early and late endothelial activation and dysfunction features such as loss of barrier integrity, morphological features, and production of pro‐inflammatory markers in a virus, dose, and time‐dependent manner. In summary, the BMVasChip model recapitulates key features of endothelial dysfunction, potentially reflecting NS1's role in viral pathogenesis and providing targets for antiviral therapeutics and vaccine development.